Compare RDY & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDY | HLI |
|---|---|---|
| Founded | 1984 | 1972 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 11.6B |
| IPO Year | 2001 | 2015 |
| Metric | RDY | HLI |
|---|---|---|
| Price | $13.84 | $138.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $16.90 | ★ $201.14 |
| AVG Volume (30 Days) | ★ 1.8M | 531.5K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | 0.51% | ★ 1.73% |
| EPS Growth | N/A | ★ 41.61 |
| EPS | N/A | ★ 4.74 |
| Revenue | N/A | ★ $2,389,416,000.00 |
| Revenue This Year | $7.50 | $14.44 |
| Revenue Next Year | $2.96 | $12.51 |
| P/E Ratio | ★ $18.67 | $29.32 |
| Revenue Growth | N/A | ★ 24.81 |
| 52 Week Low | $12.26 | $136.68 |
| 52 Week High | $16.17 | $211.78 |
| Indicator | RDY | HLI |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 22.73 |
| Support Level | $12.97 | N/A |
| Resistance Level | $14.14 | $197.84 |
| Average True Range (ATR) | 0.24 | 4.18 |
| MACD | -0.08 | -0.77 |
| Stochastic Oscillator | 3.55 | 11.11 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.